NEW YORK (October 15, 2012)—The U.S. Food and Drug Administration Monday broadened its warning to doctors about other medicines made by a specialty pharmacy linked to a meningitis outbreak.

The FDA took the step Monday because of reports of new illnesses that may be tied to other products made by the same company, the New England Compounding Center of Framingham, Mass.

Health officials now want doctors to contact patients who got any injection made by the company and warn them of the risk of infection.

A steroid made by the pharmacy has been tied to a national outbreak of a rare fungal form of meningitis that has killed 15.

The new reports include meningitis in a patient who got another company steroid and fungal infections in two heart-transplant patients.